Cross-Sector entity

Solius Pro

Product
7

Of the tracked stories, 3 of 3 also mention Solius Labs, the most common co-covered peer. Coverage clusters in fda-approval, which accounts for 1 of those 3, with the remainder spread across 2 other categories. Solius Pro appears in 3 tracked Cross-Sector stories from June 18, 2026.

3 verified stories tracked

Last mentioned: Jun 18, 2026

Entity pulse

Recent coverage · Solius Pro

3 stories
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Solius Pro

Of the tracked stories, 3 of 3 also mention Solius Labs, the most common co-covered peer. Coverage clusters in fda-approval, which accounts for 1 of those 3, with the remainder spread across 2 other categories. Solius Pro appears in 3 tracked Cross-Sector stories from June 18, 2026. The tracked stories average 2 original sources each.

Stories tracked
3
Sources per story
2

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Solius Pro. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Solius Pro 3

Startups product launch Positive 7

Solius Labs Launches Solius Pro with 99% Less UV Risk, Targets Home Market

Bainbridge Island-based startup Solius Labs announces the launch of its FDA-cleared personalized sunlight device, Solius Pro, targeting the growing consumer health and wellness market. The move positions the company at the forefront of a new category of over-the-counter light therapy without prescription.

2 sources